Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 2
2006 4
2007 1
2008 7
2009 6
2010 8
2011 8
2012 7
2013 2
2014 3
2015 4
2016 4
2017 3
2018 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean ying luan zhao (3 results)?
Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment.
Wang L, Peng W, Wu T, Deng P, Zhao YL. Wang L, et al. Among authors: zhao yl. Cell Death Discov. 2018 Aug 9;4:24. doi: 10.1038/s41420-018-0086-x. eCollection 2018. Cell Death Discov. 2018. PMID: 30109143 Free PMC article.
Current methods and research progress in nanomaterials risk assessment.
Lin H, Bu Q, Cen X, Zhao YL. Lin H, et al. Among authors: zhao yl. Curr Drug Metab. 2012 May 1;13(4):354-63. doi: 10.2174/138920012800166535. Curr Drug Metab. 2012. PMID: 22443532 Review.
#2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models.
Lu WJ, Peng W, Sun QQ, Li YH, Chen B, Yu LT, Xu YZ, Wang SY, Zhao YL. Lu WJ, et al. Among authors: zhao yl. Cell Death Discov. 2018 Feb 14;4:24. doi: 10.1038/s41420-018-0032-y. eCollection 2018 Dec. Cell Death Discov. 2018. PMID: 29531821 Free PMC article.
Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis.
Li ML, Xu YZ, Lu WJ, Li YH, Tan SS, Lin HJ, Wu TM, Li Y, Wang SY, Zhao YL. Li ML, et al. Among authors: zhao yl. Oncol Lett. 2018 Mar;15(3):2839-2846. doi: 10.3892/ol.2017.7635. Epub 2017 Dec 19. Oncol Lett. 2018. PMID: 29435010 Free PMC article.
Utilization of Caenorhabditis elegans in laboratory teaching of genetics.
Ma XY, Zhao YL, Jia FX, Song YK, Xie YC. Ma XY, et al. Among authors: zhao yl. Yi Chuan. 2017 Aug 20;39(8):763-768. doi: 10.16288/j.yczz.17-076. Yi Chuan. 2017. PMID: 28903903
Metabolomics: a revolution for novel cancer marker identification.
Bu Q, Huang Y, Yan G, Cen X, Zhao YL. Bu Q, et al. Among authors: zhao yl. Comb Chem High Throughput Screen. 2012 Mar;15(3):266-75. doi: 10.2174/138620712799218563. Comb Chem High Throughput Screen. 2012. PMID: 22221059 Review.
5-Methoxyquinoline Derivatives as a New Class of EZH2 Inhibitors.
Xiang P, Jie H, Zhou Y, Yang B, Wang HJ, Hu J, Hu J, Yang SY, Zhao YL. Xiang P, et al. Among authors: zhao yl. Molecules. 2015 Apr 27;20(5):7620-36. doi: 10.3390/molecules20057620. Molecules. 2015. PMID: 25923513 Free PMC article.
The synthesis, structure-toxicity relationship of cisplatin derivatives for the mechanism research of cisplatin-induced nephrotoxicity.
Hu J, Wu TM, Li HZ, Zuo ZP, Zhao YL, Yang L. Hu J, et al. Among authors: zhao yl. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3591-3594. doi: 10.1016/j.bmcl.2017.04.077. Epub 2017 Apr 26. Bioorg Med Chem Lett. 2017. PMID: 28579329
Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors.
Zhou Y, Li Y, Wang WJ, Xiang P, Luo XM, Yang L, Yang SY, Zhao YL. Zhou Y, et al. Among authors: zhao yl. Bioorg Med Chem Lett. 2016 Sep 15;26(18):4552-4557. doi: 10.1016/j.bmcl.2015.06.054. Epub 2015 Jun 20. Bioorg Med Chem Lett. 2016. PMID: 27524309
Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H, Zhang H, Deng P, Liu C, Li D, Jie H, Zhang H, Zhou Z, Zhao YL. Wang H, et al. Among authors: zhao yl. BMC Cancer. 2016 Jun 29;16:371. doi: 10.1186/s12885-016-2356-4. BMC Cancer. 2016. PMID: 27356757 Free PMC article.
64 results
Jump to page